David Shaw’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

David Shaw’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-30,000	Closed	-$373K	–	3796
2016 Q4	$373K	Hold	30,000	–	–	﹤0.01%	3012
2016 Q3	$411K	Buy	+30,000	New	+$301K	﹤0.01%	2891
2014 Q2	–	Sell	-11,500	Closed	-$93K	–	4766
2014 Q1	$93K	Sell	11,500 -100,300	-90%	-$781K	﹤0.01%	4179
2013 Q4	$762K	Buy	+111,800	New	+$604K	﹤0.01%	3396

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

David Shaw's ARIA Position: Q1 2017 in Review

David Shaw sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 65,062 shares — an estimated $809K sold.

David Shaw first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $7.33M in Q4 2015. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

David Shaw reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
David Shaw sold 65,062 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $809K.
David Shaw first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
David Shaw's Ariad Pharmaceuticals Inc position peaked at $7.33M in Q4 2015.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on D.E. Shaw & Co's 13F filing for Q1 2017, filed 15 May 2017.